NEWS | Oct. 6, 2021

Mongolia Receives 899,730 Additional Pfizer Vaccine Doses Donated by the United States through COVAX

Ulaanbaatar, U.S. Embassy in Mongolia -- The United States is delighted to announce that the U.S. donation of 899,730 more Pfizer COVID-19 vaccine doses has arrived in Mongolia. These doses were delivered through COVAX and came directly from the Pfizer manufacturing plant in Kalamazoo, Michigan. This donation is in addition to the 188,370 doses delivered earlier this month. The United States remains committed to supporting the people of Mongolia as they recover from this devastating pandemic. These donations through COVAX are part of that effort.

Since the beginning of the COVID-19 pandemic, The United States has provided nearly $8 million in support to Mongolia, including $3.7 million in additional urgent COVID-19 assistance provided in early September 2021. This assistance is providing life-saving medicine, testing kits, urgent medical equipment and supplies, oxygen therapy, and personal protective equipment (PPE). USAID also provided 50 high-quality ventilators in December 2020 and follow-on training needed to treat critically ill patients. USAID supports risk communication campaigns, infection prevention and control efforts in health facility and school settings, and vaccine distribution assistance.

In addition, the United States has provided critical medical equipment for more than 570 medical facilities and helped train nearly 12,700 healthcare workers to conduct outbreak surveillance, use and manage U.S. government-donated medical equipment, and deliver quality care for COVID-19 patients.

The United States, as Mongolia’s third neighbor, will continue to support the health and wellbeing of the Mongolian people.

The United States is the largest single country contributor to COVAX. The U.S. government contributed an initial $2 billion contribution to Gavi in March, which supports procurement and delivery of COVID-19 vaccines through COVAX. In July, the U.S. government provided an additional $2 billion contribution for Gavi that will help fill the gap in COVAX’s vaccine supply. This funding, along with other U.S. government funds, is being used toward the purchase of 500 million doses of Pfizer vaccine that will be made available to Gavi for distribution by COVAX to 92 low- and lower-middle-income economies around the world and the African Union.

Worldwide, the United States has provided 130 million doses of COVID-19 vaccines to 90 countries. We will continue to donate additional vaccine doses globally as supply becomes available. We are also working with U.S. vaccine manufacturers to increase vaccine supply for the rest of the world and with partners to expand global vaccine production and manufacturing capacity to beat this pandemic.